Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daidzein-rich Isoflavone-aglycones for Menopausal Symptoms
NCT00179556Phase 3Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jun 2003
- Primary completion
- Jul 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AglyMax in hot flashes, sponsored by Beth Israel Deaconess Medical Center. Started Jun 2003; status: completed.
02
Drugs
AglyMax
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT00179556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179556.